Ying-Hui Tong (Yinghui Tong)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 3

Top Topics

Small Cell Lung Cancer

Squamous Cell Carcinoma

Radiation Therapy

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Ying-Hui Tong, Hai-Ying Ding, Wen-Xiu Xin, Li-Ke Zhong, Gao-Qi Xu, Bo Zhang, Guo-Nong Yang, Luo Fang
Cost-effectiveness analysis of durvalumab plus etoposide: platinum in the first-line therapy of extensive stage small-cell lung cancer from the Chinese payers' perspective. Tumori (2021)
Wen-Xiu Xin, Haiying Ding, Qilu Fang, Xiaowei Zheng, Ying-Hui Tong, Gaoqi Xu, Guonong Yang
Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a randomised, open-label, phase III trial. BMJ open 10 (12) (2020)
Ying-Hui Tong, Ying He, Lu-Ying Hu, Yu-Jia Liu, Xiao-Wei Zheng, Jiao Sun, Yu Song, Yi-Wen Zhang, Luo Fang, Ping Huang
Elevated proportion of collapsed microvessels indicate poor survival outcome in patients with non-small cell lung cancer. Tumori 105 (6) (2019)